DE69838097D1 - Infektiöser klon für menschlichen parainfluenzavirus-typ - Google Patents

Infektiöser klon für menschlichen parainfluenzavirus-typ

Info

Publication number: DE69838097D1
Authority: DE; Germany
Prior art keywords: hpiv; clone; protein; nucleotide sequence; genome
Prior art date: 1997-05-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE69838097T

Other languages

English (en)

Other versions

DE69838097T2 (de

Inventor

Amiya K Banerjee

Michael A Hoffman

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Cleveland Clinic Foundation

Original Assignee

Cleveland Clinic Foundation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-07

Filing date

1998-05-06

Publication date

2007-08-30

1998-05-06 Application filed by Cleveland Clinic Foundation filed Critical Cleveland Clinic Foundation

2007-08-30 Application granted granted Critical

2007-08-30 Publication of DE69838097D1 publication Critical patent/DE69838097D1/de

2008-04-10 Publication of DE69838097T2 publication Critical patent/DE69838097T2/de

2018-05-07 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

208000015181 infectious disease Diseases 0.000 title abstract 2
230000002458 infectious effect Effects 0.000 title abstract 2
WKQCYNCZDDJXEK-UHFFFAOYSA-N simalikalactone C Natural products C1C(C23C)OC(=O)CC3C(C)C(=O)C(O)C2C2(C)C1C(C)C=C(OC)C2=O WKQCYNCZDDJXEK-UHFFFAOYSA-N 0.000 title 1
241000712003 Human respirovirus 3 Species 0.000 abstract 13
239000002773 nucleotide Substances 0.000 abstract 5
125000003729 nucleotide group Chemical group 0.000 abstract 5
108090000623 proteins and genes Proteins 0.000 abstract 3
102000004169 proteins and genes Human genes 0.000 abstract 3
101001065501 Escherichia phage MS2 Lysis protein Proteins 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
102000053642 Catalytic RNA Human genes 0.000 abstract 1
108090000994 Catalytic RNA Proteins 0.000 abstract 1
102000004163 DNA-directed RNA polymerases Human genes 0.000 abstract 1
108090000626 DNA-directed RNA polymerases Proteins 0.000 abstract 1
101900161954 Human parainfluenza 3 virus Phosphoprotein Proteins 0.000 abstract 1
108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
102100034574 P protein Human genes 0.000 abstract 1
101710181008 P protein Proteins 0.000 abstract 1
208000002606 Paramyxoviridae Infections Diseases 0.000 abstract 1
101710177166 Phosphoprotein Proteins 0.000 abstract 1
241000700605 Viruses Species 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
238000012258 culturing Methods 0.000 abstract 1
230000035772 mutation Effects 0.000 abstract 1
108091092562 ribozyme Proteins 0.000 abstract 1
238000003786 synthesis reaction Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18621—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18651—Methods of production or purification of viral material
- C12N2760/18652—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
General Health & Medical Sciences (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Cell Biology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

DE69838097T 1997-05-07 1998-05-06 Infektiöser klon für menschlichen parainfluenzavirus-typ Expired - Fee Related DE69838097T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US4580597P	1997-05-07	1997-05-07
US45805		1997-05-07
PCT/US1998/009270 WO1998050405A1 (en)	1997-05-07	1998-05-06	An infectious clone for human parainfluenza virus type 3

Publications (2)

Publication Number	Publication Date
DE69838097D1 true DE69838097D1 (de)	2007-08-30
DE69838097T2 DE69838097T2 (de)	2008-04-10

Family

ID=21939986

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69838097T Expired - Fee Related DE69838097T2 (de)	1997-05-07	1998-05-06	Infektiöser klon für menschlichen parainfluenzavirus-typ

Country Status (16)

Country	Link
US (1)	US6248578B1 (de)
EP (1)	EP0981537B1 (de)
JP (1)	JP2002512519A (de)
KR (2)	KR100585946B1 (de)
CN (1)	CN1208340C (de)
AT (1)	ATE367397T1 (de)
AU (1)	AU736586B2 (de)
BR (1)	BR9809240A (de)
CA (1)	CA2289776C (de)
CY (1)	CY1107730T1 (de)
DE (1)	DE69838097T2 (de)
DK (1)	DK0981537T3 (de)
ES (1)	ES2289782T3 (de)
HK (1)	HK1025973A1 (de)
PT (1)	PT981537E (de)
WO (1)	WO1998050405A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7465574B2 (en)	1994-09-30	2008-12-16	Medimmune, Llc	Recombinant RSV virus expression systems and vaccines
US6830748B1 (en)	1997-09-26	2004-12-14	Medimmune Vaccines, Inc.	Recombinant RSV virus expression systems and vaccines
US6764685B1 (en) *	2000-03-21	2004-07-20	Medimmune Vaccines, Inc.	Recombinant parainfluenza virus expression systems and vaccines
IL163646A0 (en) *	2002-02-21	2005-12-18	Vironovative Bv	Recombinant parainfluenza virus expression systemsand vaccines comprising heterologous antigens derived from metapneumovirus
US20100316991A1 (en) *	2009-06-11	2010-12-16	Utah State University	Human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assays

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5166057A (en)	1989-08-28	1992-11-24	The Mount Sinai School Of Medicine Of The City University Of New York	Recombinant negative strand rna virus expression-systems
DE69532369T3 (de)	1994-07-18	2010-11-04	Conzelmann, Karl-Klaus, Prof. Dr.	Rekombinantes infektiöses nicht-in-Segmente-geteiltes, negativ-Strange-RNS-Virus
US5869036A (en) *	1995-12-08	1999-02-09	St. Louis University	Live attenuated vaccines based on CP45 HPIV-3 strain and method to ensure attenuation in such vaccine

1998
- 1998-05-06 AU AU74731/98A patent/AU736586B2/en not_active Ceased
- 1998-05-06 PT PT98922118T patent/PT981537E/pt unknown
- 1998-05-06 ES ES98922118T patent/ES2289782T3/es not_active Expired - Lifetime
- 1998-05-06 WO PCT/US1998/009270 patent/WO1998050405A1/en active IP Right Grant
- 1998-05-06 DE DE69838097T patent/DE69838097T2/de not_active Expired - Fee Related
- 1998-05-06 KR KR1019997010246A patent/KR100585946B1/ko not_active IP Right Cessation
- 1998-05-06 DK DK98922118T patent/DK0981537T3/da active
- 1998-05-06 EP EP98922118A patent/EP0981537B1/de not_active Expired - Lifetime
- 1998-05-06 CA CA002289776A patent/CA2289776C/en not_active Expired - Fee Related
- 1998-05-06 CN CNB988048833A patent/CN1208340C/zh not_active Expired - Fee Related
- 1998-05-06 BR BR9809240-5A patent/BR9809240A/pt not_active Application Discontinuation
- 1998-05-06 KR KR1020067002175A patent/KR100678818B1/ko not_active IP Right Cessation
- 1998-05-06 US US09/073,492 patent/US6248578B1/en not_active Expired - Fee Related
- 1998-05-06 JP JP54846598A patent/JP2002512519A/ja active Pending
- 1998-05-06 AT AT98922118T patent/ATE367397T1/de not_active IP Right Cessation
2000
- 2000-08-21 HK HK00105223A patent/HK1025973A1/xx not_active IP Right Cessation
2007
- 2007-09-10 CY CY20071101163T patent/CY1107730T1/el unknown

Also Published As

Publication number	Publication date
CA2289776C (en)	2008-10-21
AU7473198A (en)	1998-11-27
KR20010012294A (ko)	2001-02-15
EP0981537B1 (de)	2007-07-18
PT981537E (pt)	2007-10-16
US6248578B1 (en)	2001-06-19
CA2289776A1 (en)	1998-11-12
KR100585946B1 (ko)	2006-06-07
ES2289782T3 (es)	2008-02-01
ATE367397T1 (de)	2007-08-15
HK1025973A1 (en)	2000-12-01
WO1998050405A1 (en)	1998-11-12
BR9809240A (pt)	2000-06-27
KR100678818B1 (ko)	2007-02-07
DK0981537T3 (da)	2007-11-19
CY1107730T1 (el)	2013-04-18
JP2002512519A (ja)	2002-04-23
KR20060014461A (ko)	2006-02-15
CN1255140A (zh)	2000-05-31
DE69838097T2 (de)	2008-04-10
AU736586B2 (en)	2001-08-02
CN1208340C (zh)	2005-06-29
EP0981537A1 (de)	2000-03-01
EP0981537A4 (de)	2002-09-18

Legal Events

Date	Code	Title	Description
2008-08-07	8364	No opposition during term of opposition
2011-03-24	8339	Ceased/non-payment of the annual fee

Publication	Publication Date	Title
Galinski et al.	1992	RNA editing in the phosphoprotein gene of the human parainfluenza virus type 3
DE69840361D1 (de)	2009-01-29	Neue knochenmineralisierungsproteine, dna, vektoren, expressionssysteme
CA2409432A1 (en)	2002-01-03	Modified morbillivirus v proteins
Meyer et al.	1995	The nucleotide sequence of the fusion protein gene of the peste des petits ruminants virus: the long untranslated region in the 5′-end of the F-protein gene of morbilliviruses seems to be specific to each virus
ES2170622A1 (es)	2002-08-01	Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
Murphy et al.	1998	A functional antigenomic promoter for the paramyxovirus simian virus 5 requires proper spacing between an essential internal segment and the 3′ terminus
AU2975699A (en)	1999-09-15	Methods for producing a polypeptide in a bacillus cell
ES8602119A1 (es)	1985-12-01	Metodo para preparar inmunoglobulinas en celulas hospedantes recombinantes
CY1105680T1 (el)	2014-07-02	Μολυσματικος κλωνος cdna βορειοαμερικανικου ιου χοιρειου αναπαραγωγικου και αναπνευστικου συνδρομου (prrs) και χρησεις αυτου
JP2007502623A (ja)	2007-02-15	膜タンパク質におけるフリンプロテアーゼ開裂部位の挿入およびその使用法
DE60024659D1 (de)	2006-01-12	Vektoren und verfahren für rekombinante proteinexpression
CN101517079A (zh)	2009-08-26	非复制型副粘病毒科病毒载体
ATE309367T1 (de)	2005-11-15	Nukleotid- und aminosäuresequenzen der gene des hüllproteins 1 und des kernproteins von hepatitis c virus
WO1995006735A3 (en)	1995-06-22	Nucleotide sequences for novel protein tyrosine phosphatases
ID27206A (id)	2001-03-08	Generasi produk-produk perbanyakan gena dari protein-protein fusi simerik melalui pemutusan endoprotease ubikuitus
Leyrer et al.	1998	Rapid and efficient recovery of Sendai virus from cDNA: factors influencing recombinant virus rescue
ATE414146T1 (de)	2008-11-15	Methoden zur herstellung von helpervirusfreien präparationen von freien rekombinenten aav- vektoren mit hohem titer
CY1107730T1 (el)	2013-04-18	Μολυσματικος κλωνος για ιο ανθρωπινης παραγριππης τυπου 3
EP0009930A1 (de)	1980-04-16	Rekombinante DNA, Verfahren zu ihrer Herstellung und Herstellung fremder Proteine durch einzellige Wirte, die sie enthalten
CA2333313A1 (en)	1999-12-09	Novel methods for rescue of rna viruses
CA2390049A1 (en)	2001-05-17	Control of post-transcriptional gene silencing in plants
Murakami et al.	1997	High-level expression of exogenous genes by replication-competent retrovirus vectors with an internal ribosomal entry site
WO1996021020A3 (en)	1996-10-17	Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
EP0378929A3 (de)	1990-08-01	Membran-Proteine und Peptide von Haemophilus influenzae Typ B
WO2002074960A3 (en)	2003-09-12	38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof